Found 10 matching trials
Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis
PHASE3Efficacy and safety study of bepotastine besilate ophthalmic solution in al...
Location
ISTA Pharmaceuticals, Inc.
Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers
PHASE3Safety study for bepotastine besilate ophthalmic solution in normal volunte...
Location
Multiple Locations
Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis Treatment
PHASE4The present study will be carried out to evaluate the antiallergic efficacy...
Location
Hospital de Alta Complejidad El Cruce - Nestor Kirchner
The Effect of BEPREVE 1.5% on Tear Film Osmolarity and Tear Film Lipid Layer
PHASE4The purpose of this study is to compare the effect of Bepreve® with an arti...
Location
Minnesota Eye Consultants, P.A.
Comparing Patient Satisfaction With Pataday or Bepreve
NAThe purpose of this study is to compare patient satisfaction with Pataday (...
Location
McCabe Vision Center
Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses
PHASE4The purpose of this study is to assess if BEPREVE (bepotastine besilate oph...
Location
Multiple Locations
The Evaluation of Bepreve on the Measurement of Wheal and Flare Response From Histamine Skin Prick Testing
PHASE4To evaluate the effect of BEPREVE compared to a REFRESH Tears Lubricant eye...
Location
North Texas Institute for Clinical Trials
Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis
PHASE2The purpose of this study is to evaluate whether bepotastine besilate ophth...
Location
ISTA Pharmaceuticals, Inc.
Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis Patients
PHASE2The purpose of this study is to study the safety and efficacy of bepotastin...
Location
ISTA Pharmaceuticals, Inc.
Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+
PHASE1Clinical phase I, controlled, non comparative, open, single center study ev...
Location
Unidad Clínica de Bioequivalencia, S. de R.L. de C.V.